PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
48.62
ESG score below 80% of SAVA's 63.11. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
63.54
Similar environmental score to SAVA's 63.13. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
30.99
Social score below 80% of SAVA's 61.04. Jim Chanos would check for potential social license and litigation risks.
51.34
Governance score below 80% of SAVA's 65.15. Jim Chanos would check for potential agency conflicts and oversight failures.